Geode Capital Management
MIST icon

Geode Capital Management’s Milestone Pharmaceuticals MIST Stock Holding History

Geode Capital Management’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.7K Hold
40,789
– – ﹤0.01% 4228
2026
Q1 		$48.5K Sell
40,789
-33,233
-45% -$58.2K ﹤0.01% 4322
2025
Q4 		$150K Hold
74,022
– – ﹤0.01% 3998
2025
Q3 		$148K Buy
74,022
+56,064
+312% +$98.6K ﹤0.01% 4024
2025
Q2 		$34.8K Sell
17,958
-1,914
-10% -$2.55K ﹤0.01% 4279
2025
Q1 		$15.9K Hold
19,872
– – ﹤0.01% 4391
2024
Q4 		$46.9K Buy
19,872
+2,296
+13% +$3.94K ﹤0.01% 4252
2024
Q3 		$26.7K Hold
17,576
– – ﹤0.01% 4366
2024
Q2 		$23.4K Hold
17,576
– – ﹤0.01% 4426
2024
Q1 		$31.5K Hold
17,576
– – ﹤0.01% 4406
2023
Q4 		$29.4K Hold
17,576
– – ﹤0.01% 4452
2023
Q3 		$54.5K Hold
17,576
– – ﹤0.01% 4402
2023
Q2 		$50.1K Hold
17,576
– – ﹤0.01% 4505
2023
Q1 		$69.2K Hold
17,576
– – ﹤0.01% 4443
2022
Q4 		$69K Hold
17,576
– – ﹤0.01% 4511
2022
Q3 		$161K Hold
17,576
– – ﹤0.01% 4329
2022
Q2 		$104K Hold
17,576
– – ﹤0.01% 4575
2022
Q1 		$112K Hold
17,576
– – ﹤0.01% 4623
2021
Q4 		$115K Hold
17,576
– – ﹤0.01% 4683
2021
Q3 		$100K Sell
17,576
-3,283
-16% -$18.5K ﹤0.01% 4675
2021
Q2 		$114K Hold
20,859
– – ﹤0.01% 4524
2021
Q1 		$120K Buy
20,859
+1,914
+10% +$14K ﹤0.01% 4260
2020
Q4 		$126K Buy
18,945
+6,150
+48% +$41.2K ﹤0.01% 4013
2020
Q3 		$93K Hold
12,795
– – ﹤0.01% 3921
2020
Q2 		$48K Buy
+12,795
New +$41.2K ﹤0.01% 3981

Other funds holding MIST

PCM
Pavaki Capital Management Pueblo, Colorado $287M AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
LPC
Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Geode Capital Management's MIST Position: Q2 2026 in Review

Geode Capital Management held its Milestone Pharmaceuticals (MIST) position steady in Q2 2026 at 40,789 shares worth $54.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4228.

Geode Capital Management first reported a position in MIST in Q2 2020 and has held it in 25 quarters since. The position peaked at $161K in Q3 2022. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

  • Geode Capital Management held 40,789 shares of Milestone Pharmaceuticals worth $54.7K as of Q2 2026.
  • Geode Capital Management left its Milestone Pharmaceuticals share count unchanged in Q2 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4228 holding.
  • Geode Capital Management first reported a position in Milestone Pharmaceuticals in Q2 2020 and has held it in 25 quarters since.
  • Geode Capital Management's Milestone Pharmaceuticals position peaked at $161K in Q3 2022.
  • 78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.